Treatment Updates in Antineutrophil Cytoplasmic ... | 合法醫療器材資訊網
由KJain著作·2021—Overthepasttwodecades,considerableprogresshasbeenmadeinmaintainingremissioninpatientswithANCAvasculitisusingavarietyof ...
IntroductionANCA vasculitides are a group of rare disorders occurring predominantly in the sixth and seventh decades of life. ANCA vasculitides can present phenotypically as granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), eosinophilic GPA, and renal-limited vasculitis with pauci-immune necrotizing and crescentic GN on review of the renal biopsy specimen. Serologically, patients may exhibit autoantibodies to myeloperoxidase (MPO-ANCA) or proteinase 3 (PR3-ANCA), with a small proportion remaining ANCA negative.
The estimated annual incidence of ANCA vasculitis is 10–20 per million (1). In the United States, the incidence and prevalence rate of GPA is 13 and 218 per million (2), compared with 8.6 and 95 per million in Australia (3), and 9.7 and 62.9 per million in the United Kingdom (4), respectively. Overall, the prevalence in people of European an...
EULARERA | 合法醫療器材資訊網
EULARERA | 合法醫療器材資訊網
Management of ANCA associated vasculitis | 合法醫療器材資訊網
Management of ANCA associated vasculitis | 合法醫療器材資訊網
Treatment of ANCA | 合法醫療器材資訊網
Treatment Updates in Antineutrophil Cytoplasmic ... | 合法醫療器材資訊網
Update in the Management of ANCA | 合法醫療器材資訊網
Update on the management of ANCA | 合法醫療器材資訊網
【黛美斯抗MPO(P-ANCA)抗體酵素免疫分析套組】許可證字號:衛署醫器輸字第023466號
器材品名:黛美斯抗MPO(P-ANCA)抗體酵素免疫分析套組許可證字號:衛署醫器輸字第023466號註銷狀態:已註銷註銷日期:2019/12/20...
【因可抗嗜中性白血球細胞質抗體(ANCA)試劑組】許可證字號:衛署醫器輸字第016342號
器材品名:因可抗嗜中性白血球細胞質抗體(ANCA)試劑組許可證字號:衛署醫器輸字第016342號註銷狀態:註銷日期:註銷理由:有效日...
【“歐蒙” 免疫膜條法抗MPO, PR3, GBM IgG抗體篩選免疫試驗系統】許可證字號:衛部醫器輸字第031404號
器材品名:“歐蒙”免疫膜條法抗MPO,PR3,GBMIgG抗體篩選免疫試驗系統許可證字號:衛部醫器輸字第031404號註銷狀態:註銷日期:註銷...
【黛美斯抗PR-3(C-ANCA)抗體酵素免疫分析套組】許可證字號:衛署醫器輸字第023450號
器材品名:黛美斯抗PR-3(C-ANCA)抗體酵素免疫分析套組許可證字號:衛署醫器輸字第023450號註銷狀態:已註銷註銷日期:2019/12/20...
【協克螢光法(c-ANCA,p-ANCA)自體免疫抗體試劑組】許可證字號:衛署醫器輸字第015228號
器材品名:協克螢光法(c-ANCA,p-ANCA)自體免疫抗體試劑組許可證字號:衛署醫器輸字第015228號註銷狀態:註銷日期:註銷理由:有效...